Trump Nominates Dr. Erica Schwartz as CDC Director

Apr 17, 2026, 2:28 AM
Image for article Trump Nominates Dr. Erica Schwartz as CDC Director

Hover over text to view sources

President Trump has officially nominated Dr Erica Schwartz to serve as the next director of the Centers for Disease Control and Prevention (CDC). Schwartz previously held the position of deputy surgeon general during Trump's first administration and has a distinguished background as a medical professional in the US military.
In a post on Truth Social, Trump praised Schwartz's credentials, stating, "Erica graduated from Brown University for College and Medical School, and served a distinguished career as a Doctor of Medicine in the United States Military, the Greatest and Most Powerful Force in the World." He expressed confidence in her ability to restore the "GOLD STANDARD OF SCIENCE at the CDC." Alongside Schwartz, Trump also announced three other appointments, including Sean Slovenski as deputy director and chief operating officer, Dr Jennifer Shuford as deputy director and chief medical officer, and Dr Sara Brenner as senior counselor for public health.
If confirmed, Schwartz will take the helm of an agency that has faced significant operational challenges and public scrutiny over the past few years. The CDC has been without a permanent director for most of Trump's second term, with Dr Jay Bhattacharya currently serving in an acting capacity. The Senate must approve Schwartz's nomination, which may take several months.
Schwartz's appointment comes at a time when the CDC faces a chaotic environment, including public firings and controversial changes to vaccine recommendations. The agency's standing has been affected by political tensions surrounding vaccine policies, particularly given Health Secretary Robert F. Kennedy Jr's outspoken views against vaccines. The administration is reportedly concerned about how Schwartz's nomination may resonate with Kennedy's supporters, who harbor skepticism toward vaccines.
Admiral Brett Giroir, who supervised Schwartz during her tenure as deputy surgeon general, commended her intellect and commitment to public service. He noted her expertise in public health, particularly in pandemic preparedness, which could be invaluable for the CDC as it navigates ongoing health crises.
Schwartz's background includes a law degree from the University of Maryland and a master's in public health from the Uniformed Services University. She has played a role in shaping pandemic policy for the US Coast Guard and is recognized for her clear communication skills and scientific integrity. Dr Georges Benjamin, the executive director of the American Public Health Association, welcomed her nomination, highlighting her qualifications and capacity for effective management.
Public health experts have expressed cautious optimism regarding Schwartz's potential confirmation. Current CDC staff hope that her leadership and the newly appointed executive team can restore order within an agency reportedly troubled by internal strife and a demoralized workforce.
As the nomination process unfolds, Schwartz will likely face scrutiny not only from the Senate but also from various public health stakeholders who are keenly observing how the new leadership will address pressing health challenges in America.
Overall, Dr Erica Schwartz's nomination reflects the Trump administration's ongoing efforts to reshape the CDC's leadership and policies amidst a turbulent public health landscape.

Related articles

Trump Nominates Dr. Erica Schwartz as CDC Director Amid Vaccine Policy Turmoil

President Donald Trump has nominated Dr Erica Schwartz, a former deputy surgeon general and vaccine supporter, to lead the CDC. This nomination comes as the agency faces significant upheaval under Health Secretary Robert F. Kennedy Jr, who has been criticized for his controversial vaccine policies.

Senate Bill 1164: A New Approach to Mental Health Interventions

Senate Bill 1164 in Texas introduces changes aimed at improving mental health interventions by allowing police to detain individuals in crisis without requiring an imminent danger. While the bill aims to provide timely support to those in need, it raises concerns regarding civil liberties and the potential for misuse.

Trump Officials Eye Fox News Regular for FDA Vaccine Role

The Trump administration is reportedly considering Houman Hemmati, a physician and Fox News regular, for a key role in overseeing vaccine regulations. If selected, Hemmati would succeed Vinay Prasad at the FDA, amid ongoing scrutiny over the agency's approach to vaccine approvals.

Delay in CDC Vaccine Study Raises Concerns Over Political Interference

The acting director of the CDC, Dr Jay Bhattacharya, has delayed the publication of a study demonstrating the effectiveness of Covid vaccines in preventing severe illness. Critics suggest this move reflects a broader trend of political interference in health research under the Trump administration.

Trump Administration Cuts Drug Prices for GLP-1 and Fertility Medications

The Trump administration's recent initiatives have led to significant reductions in drug prices, particularly for GLP-1 medications and fertility treatments. Medicare Director Chris Klomp noted that these changes aim to improve affordability for many Americans, allowing easier access to essential medications.